NCT03009656 (HOGAN) is a clinical trial of No study specific interventions in Stroke Syndrome, sponsored by Insel Gruppe AG, University Hospital Bern.

Who is sponsoring NCT03009656?

NCT03009656 is sponsored by Insel Gruppe AG, University Hospital Bern.

What drugs are being tested in NCT03009656?

Interventions in NCT03009656: No study specific interventions.

What condition does NCT03009656 study?

NCT03009656 studies Stroke Syndrome, Stroke Hemorrhagic, Stroke, Acute, Strokes Thrombotic, Emergencies, Diagnostic Self Evaluation.

Is NCT03009656 still recruiting?

NCT03009656 is currently status unknown. Last updated 8 July 2019.

Last reviewed 2019-07-08 · How we verify

NCT03009656: HOGAN

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessing Accuracy of Clinical Diagnosis and Lesion Location in Acute Neurological Deficits - How Good Are Neurologists?

Status unknown Last updated 8 July 2019

What this trial tests

trial testing No study specific interventions in Stroke Syndrome in 800 participants. Status unknown.

Timeline

10 January 2017

Primary endpoint
31 December 2020

31 December 2020

Quick facts

Lead sponsor	Insel Gruppe AG, University Hospital Bern
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	800
Start date	10 January 2017
Primary completion	31 December 2020
Estimated completion	31 December 2020
Sites	1 location across Switzerland

Drugs / interventions tested

No study specific interventions

Conditions studied

Stroke Syndrome — all drugs for Stroke Syndrome →
Stroke Hemorrhagic — all drugs for Stroke Hemorrhagic →
Stroke, Acute — all drugs for Stroke, Acute →
Strokes Thrombotic — all drugs for Strokes Thrombotic →

Sponsor

Insel Gruppe AG, University Hospital Bern

Who can join

18 and older, any sex, with Stroke Syndrome or Stroke Hemorrhagic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The emergency setting for acute neurological conditions, such as stroke, is peculiar due to time pressure and limited resources for further diagnostics. Clinical skills are essential for swift and accurate bedside diagnosis and thus are the basis for early and correct treatment. This is especially evident in the context of computed tomography being the standard neuroimaging method world-wide with its limitations for detecting smaller infarcts, strokes in the posterior fossa and reduced sensitivity for stroke mimics, such as epileptic seizures or migraine aura. To date, the accuracy of clinical bedside diagnosis of stroke by neurologists verified by magnetic resonance imaging (MRI) in the emergency setting has not been studied in detail. In order to improve clinical diagnosing and future treatment it is essential to quantify the accuracy of clinical diagnosis of stroke in the emergency setting ("how good are neurologists?") and to assesses whether there are any differences between experienced staff neurologists and junior physicians.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

How Good Are Neurologists? A Diagnostic Accuracy Study on the Performance of Neurologists in the Emergency Room.
Schankin CJ, Popa-Todirenchi BV, Eich AS, Branca M, et al · · 2025 · PMID 41573182 · DOI 10.1161/svin.124.001612

Verify or expand the search:

Other recruiting trials for Stroke Syndrome

Currently open trials in the same condition.

NCT03592563 — CUHK Brain Health Longitudinal Study · recruiting

Other Insel Gruppe AG, University Hospital Bern trials

Trials by the same sponsor.

NCT06546384 — GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Disease · NA · not yet recruiting
NCT07524049 — Giving Children a Voice in Paediatric Anaesthesia · not yet recruiting
NCT07415668 — Motor Eloquent Navigated Transcranial Magnetic Stimulation for Radiosurgery Planning · NA · not yet recruiting
NCT07478536 — Stockholm3 Test Validation in Men on Active Surveillance in Switzerland (CHAS3 Trial) · not yet recruiting
NCT07201506 — Real-Time Intracardiac Echocardiography for Ventricular Arrhythmia Ablation · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03009656 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Insel Gruppe AG, University Hospital Bern
Last refreshed: 8 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03009656.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing